Marketing-authorisation holder · United States
Novast Labs
34 medicines in 1 country, as authorisation holder.
Group structure
Part of
NovastPharmaceutical groupOther companies in the group
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 34
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAZOLAMIDE500mg · Capsule, extended release | Acetazolamide | United States | Marketed | 2008 |
| CHABELINA FE0.02mg,0.03mg,0.035mg; 1mg,1mg,1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2020 |
| CLONIDINE HYDROCHLORIDE0.1mg | 0.2mg · Tablet, extended release | Clonidine | United States | Marketed | 2013 |
| CONJUGATED ESTROGENS0.3mg | 0.45mg | 0.625mg | 0.9mg | 1.25mg · Tablet | Conjugated estrogens, Conjugated | United States | Marketed | 2025 |
| DASETTA 1/350.035mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2011 |
| DASETTA 7/7/70.035mg,0.035mg,0.035mg; 0.5mg,0.75mg,1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2011 |
| DOLISHALE0.02mg; 0.09mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2020 |
| DROSPIRENONE AND ESTRADIOL0.5mg; 1mg · Tablet | Drospirenone, Estradiol | United States | Marketed | 2025 |
| ELINEST0.03mg; 0.3mg · Tablet | Ethinyl estradiol, Norgestrel | United States | Marketed | 2012 |
| FALMINA0.02mg; 0.1mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2012 |
| HER STYLE1.5mg · Tablet | Levonorgestrel | United States | Marketed | 2016 |
| LARIN 1/200.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2013 |
| LARIN 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2014 |
| LARIN 24 FE0.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2015 |
| LARIN FE 1/200.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2013 |
| LARIN FE 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2013 |
| LERIBANE0.0025mg; 0.5mg | 0.005mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2016 |
| LEVONEST0.03mg,0.04mg,0.03mg; 0.05mg,0.075mg,0.125mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2010 |
| LO-MALMOREDE0.035mg; 1mg · Tablet | Ethinyl estradiol, Ethynodiol diacetate | United States | Marketed | 2019 |
| MALMOREDE0.05mg; 1mg · Tablet | Ethinyl estradiol, Ethynodiol diacetate | United States | Marketed | 2018 |
| MELAMISA3mg; 0.02mg · Tablet | Drospirenone, Ethinyl estradiol | United States | Marketed | 2016 |
| MONO-LINYAH0.035mg; 0.25mg · Tablet | Ethinyl estradiol, Norgestimate | United States | Marketed | 2012 |
| PHILITH0.035mg; 0.4mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2011 |
| PIMTREA0.15mg,n/a; 0.02mg,0.01mg · Tablet | Desogestrel, N/a, Ethinyl estradiol | United States | Marketed | 2013 |
| QUETIAPINE FUMARATE150mg base | 200mg base | 300mg base | 400mg base | 50mg base · Tablet, extended release | Quetiapine | United States | Marketed | 2016 |